Literature DB >> 2672367

Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine.

C R Brockelman1, P Tan-Ariya, D Bunnag.   

Abstract

An in vitro microtest to assess P. vivax sensitivity to chloroquine has been developed using a medium mixture which contained RPMI, Waymouth (GIBCO) and 15% (vol/vol) human serum group AB. The rate of success was highest in samples which were not washed by centrifugation before culturing in microtest plates predosed with varying concentrations of chloroquine. Evaluation of the effective concentration of chloroquine using a program for probit analysis of log dose/response test proved superior to simply using the percentage of schizont maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672367

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

Review 1.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Short-term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing.

Authors:  L K Basco; J Le Bras
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.

Authors:  Pierre Druilhe; Philippe Brasseur; Catherine Blanc; Michael Makler
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

4.  The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.

Authors:  K Na-Bangchang; L Limpaibul; A Thanavibul; P Tan-Ariya; J Karbwang
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

Review 5.  In vitro drug sensitivity testing in Plasmodium vivax.

Authors:  Walther H Wernsdorfer; Oumaporn Tasanor; Gunther Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.